The content of this program is supported by an unrestricted educational grant from Novartis Inc and Bristol Myers Squibb (BMS).
The MDS Iron Road was developed and approved by a Steering Committee with the input of 18 Canadian hematologists from the Canadian Consortium on MDS (CCMDS). The opinions expressed are solely those of the Iron Road hematologists. The content is specifically intended to be used by qualified physicians/medical professionals, to assist them in the management of iron overload in MDS patients. The MDS Iron Road does not substitute, nor is it intended to substitute for the medical advice of an appropriately qualified and licensed physician or other healthcare provider. Use of the application is undertaken entirely on your own responsibility as a healthcare professional. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. The digital formats of the MDS Iron Road have been completed by The Adpharm Inc. (a healthcare communications company) through funding from Novartis Inc. The sole purpose was to deliver the content of the original MDS Iron Road in a user friendly, digital format. No content was modified in the transition to a digital format. All digital formats are the property of the CCMDS. This presentation may include indications and treatment regimens which are not authorized in Canada. Please refer to current product monographs for complete indication and safety information.